|

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

RECRUITINGSponsored by University Hospital, Brest
Actively Recruiting
SponsorUniversity Hospital, Brest
Started2024-06-01
Est. completion2028-01-31
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT06462664

Summary

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Diagnosis of MPN in the participating center
* Over 18 yo

Exclusion Criteria:

* Not able to consent

Conditions2

CancerMyeloproliferative Neoplasm

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.